The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline
 
Consulting or Advisory Role - Debiopharm Group; Roche; TFS
Travel, Accommodations, Expenses - Merck Serono; Roche
INDUCE-1: Report on safety run-in cohorts combining Inducible T-cell co-stimulatory receptor (ICOS) agonist GSK3359609 (GSK609) with platinum+5-FU chemotherapy (5-FU/plat), with or without pembrolizumab (PE), for the treatment of advanced solid tumors.
 
Erminia Massarelli
Honoraria - AstraZeneca; Merck
Consulting or Advisory Role - Genentech/Roche; Nektar
Speakers' Bureau - AstraZeneca; Merck
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Merck (Inst); Pfizer (Inst); Tessa Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Pfizer
 
Ani Sarkis Balmanoukian
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Genentech; Merck
 
Maria Vieito
No Relationships to Disclose
 
Christophe Le Tourneau
Honoraria - Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Merck Serono; MSD; Nanobiotix; Novartis; Rakuten Medical; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; MSD; Nanobiotix; Roche
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD
 
Tatiana Hernandez-Guerrero
No Relationships to Disclose
 
Jose Manuel Trigo
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; MSD; Takeda
Speakers' Bureau - AstraZeneca; Bayer; Eisai; MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Raid Aljumaily
Consulting or Advisory Role - AstraZeneca; Regeneron
Research Funding - Abbvie; Array BioPharma; AstraZeneca; Baxalta; Boehringer Ingelheim; Bristol-Myers Squibb; Checkpoint Therapeutics; EMD Serono; G1 Therapeutics; Genentech; GlaxoSmithKline; Huntsman Cancer Institute; Lilly; MedImmune; Merck; Novartis; Peloton Therapeutics; Regeneron; Tesaro
Travel, Accommodations, Expenses - Sarah Cannon Research Institute
 
Michael Jon Chisamore
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Debra Rogan
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline; GlaxoSmithKline (Inst)
Research Funding - GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline (Inst)
 
Ruby Sung
Employment - GlaxoSmithKline
 
Courtney Henry
Employment - GlaxoSmithKline
 
David Turner
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Sapna Yadavilli
No Relationships to Disclose
 
Sonia Franco
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Catherine Elizabeth Ellis
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Marc S. Ballas
Employment - GlaxoSmithKline
Leadership - GlaxoSmithKline
Stock and Other Ownership Interests - Bristol-Myers Squibb; GlaxoSmithKline
Research Funding - GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - AstraZeneca; GlaxoSmithKline
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Axel Hoos
Employment - GlaxoSmithKline
Leadership - Imugene
Stock and Other Ownership Interests - GlaxoSmithKline; Imugene
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline (Inst)
Other Relationship - Board member Sabin Institute, CRI
 
Danny Rischin
Research Funding - Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Merck; Regeneron
Travel, Accommodations, Expenses - Merck